---
title: SciRhom
date: 2019-11-12T11:57:48Z
modified: 2026-08-12T08:31:38Z
permalink: "https://www.htgf.de/en/portfolio/htgffamily/scirhom/"
type: portfolio
status: publish
excerpt: ""
wpid: 74456
language:
  - English
post_translations:
  - pll_5dca853f47e5d
branchen22:
  - Immunology
sectors:
  - Pharmaceuticals
focus_areas:
  - Immunology
timestamp: 2026-08-12T08:31:38Z
tags:
  - English
  - pll_5dca853f47e5d
  - Immunology
  - Pharmaceuticals
---

## Beschreibungstext

SciRhom GmbH is a therapeutic antibody company developing first-in-class antibodies against iRhom2, a key modulator of several major pro-inflammatory signaling pathways, including TNF-alpha signaling. Based on a decade of cutting-edge bench research and the completion of a challenging, yet ultimately successful antibody campaign, SciRhom is now in the unique position to pursue the development of monoclonal antibodies against iRhom2 for the treatment of major autoimmune diseases.

## Unternehmenswebsite

https://scirhom.com/

## Adresse

Am Klopferspitz 19
82152 Planegg/Martinsried
Deutschland

## Kontakt

Array

Array